Loading
Life sciences · Journal article
Frontiers in Immunology · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
High-salt diet (HSD) has traditionally been studied in the context of cardiovascular disease, hypertension, and kidney disease. Increasing evidence now suggests that salt intake may also influence cancer immunity through direct effects on immune cells and indirect effects mediated by the gut microbiota. HSD can regulate inflammatory activation in T cells, macrophages, NK cells, and other immune populations. It can also reshape gut microbial composition and alter microbial metabolites, including short-chain fatty acids (SCFAs), bile acids (BAs), and tryptophan (Trp) metabolites. These changes may affect immune homeostasis, inflammatory signaling, and the tumor microenvironment. Current evidence suggests that the HSD-microbiota-immune axis has context-dependent roles in cancer biology. In some experimental settings, HSD may enhance antitumor immune responses, whereas chronic exposure may promote inflammation, immune exhaustion, microbial dysbiosis, and tumor progression. In this review, we summarize how HSD interacts with the gut microbiota and immune system, discuss its potential bidirectional effects on cancer initiation and progression, and highlight future directions for diet-microbiota-immune interventions in cancer prevention and therapy.